Santana Lucas Matheus Barreto, de Moura Ingrid Andrêssa, Mouzinho Ramos Tanaka Yuri, França Rafael Freitas de Oliveira
Department of Virology and Experimental Therapy, Fundação Oswaldo Cruz/Fiocruz, Recife 50740-465, PE, Brazil.
Laboratory of Molecular Studies and Experimental Therapy-LEMTE, Department of Genetics, Federal University of Pernambuco, Recife 50740-465, PE, Brazil.
Viruses. 2025 Apr 28;17(5):637. doi: 10.3390/v17050637.
The Zika virus (ZIKV) gained prominence as a significant global pathogen after the 2015-2016 outbreaks associated it with an increase in neurological complications in adults and congenital malformations. Different mechanisms have been proposed by which ZIKV may cross the blood-brain barrier and reach the central nervous system to cause neuroinflammation. Although ZIKV infection triggers a robust immune response, the virus has developed different strategies to escape it. Furthermore, although the virus is present in areas with cocirculation of other pathogenic agents, few studies have evaluated the cross-immune reactions and coinfection of ZIKV. Coinfections of ZIKV with other viruses, parasites, and bacteria are described. Such interactions can worsen infections and alter the immune response, imposing new therapeutic challenges and highlighting the need for more studies in the field. In this review, we discuss various aspects of ZIKV biology, focusing on the impacts of coinfections.
寨卡病毒(ZIKV)在2015 - 2016年疫情爆发后,因与成人神经并发症增加以及先天性畸形相关联,成为一种重要的全球病原体。人们提出了不同的机制,ZIKV可能通过这些机制穿过血脑屏障并到达中枢神经系统,从而引发神经炎症。尽管ZIKV感染会引发强烈的免疫反应,但该病毒已发展出不同的策略来逃避这种反应。此外,尽管该病毒存在于其他病原体共同流行的地区,但很少有研究评估ZIKV的交叉免疫反应和合并感染情况。本文描述了ZIKV与其他病毒、寄生虫和细菌的合并感染。这种相互作用会使感染恶化并改变免疫反应,带来新的治疗挑战,并凸显了该领域开展更多研究的必要性。在本综述中,我们讨论了ZIKV生物学的各个方面,重点关注合并感染的影响。